CN Patent

CN103254126A — 氘代的ω-二苯基脲及衍生物以及包含该化合物的药物组合物

Assigned to Suzhou Zelgen Biopharmaceutical Co Ltd · Expires 2013-08-21 · 13y expired

What this patent protects

本发明涉及氘代的ω-二苯基脲及衍生物以及药学上可接受的盐。本发明还涉及含有药物学上可接受的载体和氘代的ω-二苯基脲及衍生物以及药学上可接受的盐的药物组合物。本发明的氘代二苯基脲可用于治疗和预防癌症以及相关的疾病。

USPTO Abstract

本发明涉及氘代的ω-二苯基脲及衍生物以及药学上可接受的盐。本发明还涉及含有药物学上可接受的载体和氘代的ω-二苯基脲及衍生物以及药学上可接受的盐的药物组合物。本发明的氘代二苯基脲可用于治疗和预防癌症以及相关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN103254126A
Jurisdiction
CN
Classification
—
Expires
2013-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Zelgen Biopharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.